Francisco Rivas García

Dr. Francisco Rivas García

Municipal Health and Consumer Unit, Guadix City Council, Guadix, Andalusia, Spain
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RGRafael Jesús Giménez-Martínez
Rafael Jesús Giménez-Martínez
Francisco Rivas GarcíaFrancisco Rivas García
Francisco Rivas García
JCJoan Carles March Cerdá
Joan Carles March Cerdá
Ángela Hernández-RuizÁngela Hernández-Ruiz
Ángela Hernández-Ruiz
MCMartha Irene González Castro
Martha Irene González Castro
LGLopez-Viota Gallardo
Lopez-Viota Gallardo
The skin is one of the largest and most important organs of our body. There are numerous factors that are related to skin health, including lifestyle factors, nutrition, or skin care. Bioactive substances from plant and marine extracts play a key role in skin health. The aim of this research was to compile the main evidence on skin and bioactive substances. An integrative review was performed, reporting the main findings according to PRISMA (2020). Thirteen search equations were developed. After the applications of the equations and the process of screening and selection of articles, 95 references were compiled. The main results related to bioactive compounds were classified into food-derived components, nutraceuticals, symbiotics, active substances of marine origin, and substances from plant extracts). There are several factors that indicate that the use of bioactive compounds are interesting for skin health, highlighting some dietary nutrients, substances obtained from plant extracts and metabolites of marine origin that, showing anti-inflammatory and antimicrobial effects, are related to the improvement of some skin conditions or are active principles for cosmetics.

9 December 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Francisco Rivas GarcíaFrancisco Rivas García
Francisco Rivas García
Jose Antonio García SierraJose Antonio García Sierra
Jose Antonio García Sierra
María-Isabel Valverde-MerinoMaría-Isabel Valverde-Merino
María-Isabel Valverde-Merino
MZMaria Jose Zarzuelo
Maria Jose Zarzuelo
Food supplements are used for a variety of purposes, one of which is weight reduction. As excess weight is a long-term condition, some supplements are expected to be used for long periods of time. The long-term use of these dietary supplements makes it highly likely that they will be combined with medications, increasing the risk of food supplement–drug interactions, which are not always known or disclosed, and can lead to serious health problems, as has been observed. This article discusses some of the compounds used as food supplements for weight reduction (green tea extract, Garcinia cambogia, chitosan, quercetin and resveratrol) and the interactions they may cause with some drugs such as: dextromethorphan, buspirone, diclofenac, irinotecan, 5-fluorouracil, cytochrome P450 inducers and inhibitors, statins, orlistat, warfarina, acenocoumarol, fluoxetine, valproate, quetiapine, carbamazepine. This information is expected to be useful for healthcare professionals to detect and intervene on food supplement–drug interactions to ensure the optimization of therapy and patient safety.

8 March 2022 in Revista Iberoamericana de Bioética
Verified
Journal Article
Open access
PDF file
Francisco Rivas GarcíaFrancisco Rivas García
Francisco Rivas García
La sedación paliativa es una práctica clínica ampliamente asumida y aplicada en situaciones que anticipan el final de la vida. No obstante, a pesar de sus beneficios cuando los síntomas refractarios no tienen otra alternativa, en algunas ocasiones la sedación puede ser fuente de numerosos dilemas bioéticos relacionados con el principio de doble efecto que actúa como una de las herramientas base, en el ámbito de la bioética, sobre las que puede sustentarse la licitud de la sedación en el final de la vida.

20 December 2022 in Ars Pharmaceutica (Internet)
Verified
Journal Article
Open access
PDF file
Francisco Rivas GarcíaFrancisco Rivas García
Francisco Rivas García
MGMargarita López-Viota Gallardo
Margarita López-Viota Gallardo
Introducción: La Nutrición Parenteral (NP) es un medio para proporcionar los nutrientes necesarios por vía intravenosa, cuando la situación clínica lo requiere. El aporte de NP conlleva un riesgo debido al carácter invasivo del procedimiento, que suele variar según el tipo utilizado. Por ello, los productos sanitarios empleados deben ser caracterizados conforme a los criterios de seguridad, comodidad, efectividad y coste económico para optimizar y maximizar los recursos disponibles en la administración de la NP. Método: Se realizó una revisión bibliográfica narrativa basada en la búsqueda, en distintas bases de datos tales como Medline, Science Direct y Scopus, de todos los artículos publicados, hasta marzo de 2022 sobre dispositivos para la administración de NP. Resultados y discusión: La administración de NP requiere de dispositivos sanitarios que garanticen las propiedades tecno-farmacéuticas de la NP, así como la seguridad en su administración. Conclusiones: Las bolsas y bombas de infusión junto con los catéteres constituyen los dispositivos clave sobre los que se debe seguir mejorando sus características y sistemas de seguridad con objeto de garantizar una optimización de la NP administrada.

13 November 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FLFernando Lopez-Carmona
Fernando Lopez-Carmona
ARAntonio Toro Ruiz
Antonio Toro Ruiz
CPCelia Piquer-Martinez
Celia Piquer-Martinez
Manuel Gómez-GuzmánManuel Gómez-Guzmán
Manuel Gómez-Guzmán
FAFrancisco Javier Ferreira Alfaya
Francisco Javier Ferreira Alfaya
MZMaria Jose Zarzuelo
Maria Jose Zarzuelo
Background/Objectives: Vitamin D deficiency is highly prevalent worldwide and is associated with multiple comorbidities and pharmacological treatments that may interfere with its metabolism. Evidence on the effect of supplementation across different drug user groups remains limited. Methods: A prospective study was conducted across community pharmacies over twelve months. Baseline socio-demographic, serum 25(OH)D concentration, quality of life (QoL), lifestyle habits, and medication use were collected. Participants received vitamin D supplementation for 12 months. Changes in vitamin D status and QoL were analyzed according to medication use. Logistic regression identified predictors of achieving adequate serum vitamin D levels (>30 ng/mL). Statistical significance was set at p < 0.05. Results: At baseline, 87.2% of 210 participants had insufficient or deficient vitamin D levels. After supplementation, mean serum vitamin D increased significantly from 21.3 ± 8.2 to 32.1 ± 12.6 ng/mL (p < 0.001), and QoL scores improved from 68.6 ± 18.7 to 77.8 ± 18.5 (p < 0.001). Dietary intake of vitamin D–rich foods and outdoor activity also increased. Supplementation improved vitamin D status among users of benzodiazepines, proton pump inhibitors, beta-blockers, statins, levothyroxine, metformin, and angiotensin-converting enzyme inhibitors, but not among corticosteroid, nonsteroidal anti-inflammatory drugs, or vitamin K antagonist. Multivariate analysis confirmed adherence as a strongest predictor of vitamin D adequacy (OR = 15.31, 95% CI = 2.90–80.75), while corticosteroid therapy, diabetes, and hypercholesterolemia were negatively associated. Conclusions: Vitamin D supplementation effectively corrected deficiency and improved QoL, but its efficacy varied according to comorbidities and medication use. Personalized supplementation strategies, emphasizing adherence and considering pharmacological profiles, may optimize outcomes. Further studies should explore mechanistic drug–nutrient interactions and long-term clinical implications.

30 October 2017 in Revista Iberoamericana de Bioética
Verified
Journal Article
Open access
PDF file
Francisco Rivas GarcíaFrancisco Rivas García
Francisco Rivas García
Son numerosas y variadas las patologías que pueden desembocar en un estado de enfermedad terminal, provocando numerosos dilemas bioéticos que son inherentes y específicos a cada circunstancia personal y médica.El presente trabajo tiene como objetivo proporcionar un análisis actual y útil que pueda ayudar a comprender los principales problemas que genera una enfermedad terminal, desde la perspectiva del bioderecho y que deben ser resueltos en el inevitable camino hacia el final de la vida. La metodología utilizada ha incluido un estudio de documentación bibliográfica mediante consulta de bases de datos especializadas.Se concluye que el bioderecho es una herramienta muy útil que permite ayudar en el análisis y toma de decisiones por parte de los profesionales sanitarios y familiares cuando sobreviene una enfermedad terminal. Independientemente de la práctica médica basada en los protocolos y el conocimiento científico, es necesario garantizar que no todo lo que legalmente pueda realizarse, sea aceptado en el ámbito del bioderecho.